Revenue
905 thousand USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 905000 USD Source
Annual consolidated revenue for 2025: about USD 25.42M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 210.8M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-19.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
905 thousand USD
2026 Q3 · USD
-4,606.52%
2026 Q3 · %
-30 million USD
2026 Q3 · USD
-30.1 million USD
2026 Q3 · USD
112238000 USD
39150334 shares
2.44% · 931 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
3.98 million USD
2025-10-01 – 2026-09-30
-161 million USD
2025-10-01 – 2026-09-30
-136 million USD
2025-10-01 – 2026-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-05.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 210.78 million
–
Current period
USD 25.42 million
–
25421000 − 210782000 = -185361000 USD
210782000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source25421000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 65.63 million
–
Current period
−USD 143.75 million
–
-143750000 − 65626000 = -209376000 USD
65626000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-143750000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 41.56 million
–
Current period
−USD 128.51 million
–
-128512000 − -41557000 = -86955000 USD
-41557000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-128512000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 3.16 million
–
Current period
USD 1.04 million
–
1041000 − 3158000 = -2117000 USD
3158000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1041000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 129013000 | 132175000 Derived | -3162000 | 3523000 Derived | -6685000 | 134189000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 210782000 | 163771000 Derived | 47011000 | -18615000 Derived | 65626000 | -44715000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 25421000 | 183319000 Derived | -157898000 | -14148000 Derived | -143750000 | -129553000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 129013000 |
|
| 2024 | Revenue | 210782000 |
|
| 2025 | Revenue | 25421000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 63.4% |
|
| 2025 | Year over year | -87.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -2.5% |
|
| 2024 | Operating margin | 22.3% |
|
| 2025 | Operating margin | -621.1% |
|
| 2023 | Net margin | -5.2% |
|
| 2024 | Net margin | 31.1% |
|
| 2025 | Net margin | -565.5% |
|
| 2023 | Free cash flow margin | 104% |
|
| 2024 | Free cash flow margin | -21.2% |
|
| 2025 | Free cash flow margin | -509.6% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | 139803000 |
|
| 2024 | Operating cash flow | -41557000 |
|
| 2025 | Operating cash flow | -128512000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | 134189000 |
|
| 2024 | Free cash flow | -44715000 |
|
| 2025 | Free cash flow | -129553000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 48.3% |
|
| 2024 | Liabilities / assets | 18.6% |
|
| 2025 | Liabilities / assets | 18.9% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 2.33× |
|
| 2024 | Current assets / current liabilities | 11.15× |
|
| 2025 | Current assets / current liabilities | 12.53× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 26.52 million Exact valueExact value: -26523000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.57 million Exact valueExact value: -25570000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.32 million Exact valueExact value: 2318000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.89 million Calculation and evidence-25570000 − 2318000 USD Exact free cash flow: -27888000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 51.16 million Exact valueExact value: -51158000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 50.86 million Exact valueExact value: -50862000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.58 million Exact valueExact value: 4580000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 55.44 million Calculation and evidence-50862000 − 4580000 USD Exact free cash flow: -55442000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 94.6 million Exact valueExact value: -94600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 93.79 million Exact valueExact value: -93786000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.89 million Exact valueExact value: 2887000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 96.67 million Calculation and evidence-93786000 − 2887000 USD Exact free cash flow: -96673000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 6.69 million Exact valueExact value: -6685000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 139.8 million Exact valueExact value: 139803000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.61 million Exact valueExact value: 5614000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 134.19 million Calculation and evidence139803000 − 5614000 USD Exact free cash flow: 134189000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | USD 65.63 million Exact valueExact value: 65626000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 41.56 million Exact valueExact value: -41557000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.16 million Exact valueExact value: 3158000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 44.72 million Calculation and evidence-41557000 − 3158000 USD Exact free cash flow: -44715000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 143.75 million Exact valueExact value: -143750000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 128.51 million Exact valueExact value: -128512000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.04 million Exact valueExact value: 1041000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 129.55 million Calculation and evidence-128512000 − 1041000 USD Exact free cash flow: -129553000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
38 filings · 1,499 latest values · 1,499 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001689375, 1689375, TRDA, edgar:1689375
Also known as CycloPorters, Inc., ENTRADA THERAPEUTICS, INC., Entrada Therapeutics, Inc.